The NMDA antagonist memantine affects training induced motor cortex plasticity - A study using transcranial magnetic stimulation [ISRCTN65784760]

BMC Neuroscience

Volumn 6, Issue , 2005, Pages

  Schwenkreis, Peter ^a   Witscher, Katja ^a   Pleger, Burkhard ^a   Malin, Jean Pierre ^a   Tegenthoff, Martin ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO; AMINO ACID RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DELTOID MUSCLE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR CORTEX; MUSCLE CONTRACTION; NERVE CELL PLASTICITY; PHANTOM PAIN; RANDOMIZED CONTROLLED TRIAL; TRAINING; TRANSCRANIAL MAGNETIC STIMULATION; ANALYSIS OF VARIANCE; BLOOD; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DRUG ANTAGONISM; DRUG EFFECT; METHODOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MALE; MEMANTINE; MOTOR CORTEX; N-METHYLASPARTATE; NEURONAL PLASTICITY; PSYCHOMOTOR PERFORMANCE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 26444432909     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-6-35     Document Type: Article

References (46)

1. Wassermann EM, McShane LM, Hallett M, Cohen LG: Noninvasive mapping of muscle representations in human motor cortex. Electroencephalogr Clin Neurophysiol 1992, 85:1-8.
2. Wassermann EM, Pascual-Leone A, Valls-Sole J, Toro C, Cohen LG, Hallett M: Topography of the inhibitory and excitatory responses to transcranial magnetic stimulation in a hand muscle. Electroencephalogr Clin Neurophysiol 1993, 89:424-433.
3. Liepert J, Tegenthoff M, Malin JP: Changes of cortical motor area size during immobilization. Electroencephalogr Clin Neurophysiol 1995, 97:382-386.
4. Classen J, Knorr U, Werhahn KJ, Schlaug G, Kunesch E, Cohen LG, Seitz RJ, Benecke R: Multimodal output mapping of human central motor representation on different spatial scales. J Physiol 1998, 512:163-179.
5. Schwenkreis P, Witscher K, Janssen F, Pleger B, Dertwinkel R, Zenz M, Malin JP, Tegenthoff M: Assessment of reorganization in the sensorimotor cortex after upper limb amputation. Clin Neurophysiol 2001, 112:627-635.
6. Wilson SA, Thickbroom GW, Mastaglia FL: Transcranial magnetic stimulation mapping of the motor cortex in normal subjects. The representation of two intrinsic hand muscles. J Neurol Sci 1993, 118:134-144.
7. Mortifee P, Stewart H, Schulzer M, Eisen A: Reliability of transcranial magnetic stimulation for mapping the human motor cortex. Electroencephalogr Clin Neurophysiol 1994, 93:131-137.
8. Uy J, Ridding MC, Miles TS: Stability of maps of human motor cortex made with transcranial magnetic stimulation. Brain Topogr 2002, 14:293-297.
9. Cohen LG, Gerloff C, Ikoma K, Hallett M: Plasticity of motor cortex elicited by training of synchronous movements of hand and shoulder. Soc Neurosci Abstr 1995, 21:517.
10. Liepert J, Terborg C, Weiller C: Motor plasticity induced by synchronized thumb and foot movements. Exp Brain Res 1999, 125:435-439.
11. Tegenthoff M, Witscher K, Schwenkreis P, Liepert J: Pharmacological modulation of training-induced plastic changes in human motor cortex. Electroencephalogr Clin Neurophysiol Suppl 1999, 51:188-196.
12. Tegenthoff M, Cornelius B, Pleger B, Malin JP, Schwenkreis P: Amphetamine enhances training-induced motor cortex plasticity. Acta Neurol Scand 2004, 109:330-336.
13. Pleger B, Schwenkreis P, Grunberg C, Malin JP, Tegenthoff M: Fluoxetine facilitates use-dependent excitability of human primary motor cortex. Clin Neurophysiol 2004, 115:2157-2163.
14. Classen J, Liepert J, Wise SP, Hallett M, Cohen LG: Rapid plasticity of human cortical movement representation induced by practice. J Neurophysiol 1998, 79:1117-1123.
15. Bütefisch CM, Davis BC, Wise SP, Sawaki L, Kopylev L, Classen J, Cohen LG: Mechanisms of use-dependent plasticity in the human motor cortex. Proc Natl Acad Sci USA 2000, 97:3661-3665.
16. Bütefisch CM, Davis BC, Sawaki L, Waldvogel D, Classen J, Kopylev L, Cohen LG: Modulation of use-dependent plasticity by d-amphetamine. Ann Neurol 2002, 51:59-68.
17. Pleger B, Dinse HR, Ragert P, Schwenkreis P, Malin JP, Tegenthoff M: Shifts in cortical representations predict human discrimination improvement. Proc Natl Acad Sci U S A 2001, 98:12255-12260.
18. Dinse HR, Ragert P, Pleger B, Schwenkreis P, Tegenthoff M: Pharmacological modulation of perceptual learning and associated cortical reorganization. Science 2003, 301:91-94.
19. Dinse HR, Ragert P, Pleger B, Schwenkreis P, Tegenthoff M: GABAergic mechanisms gate tactile discrimination learning. Neuroreport 2003, 14:1747-1751.
20. Jacobs KM, Donoghue JP: Reshaping the cortical motor map by unmasking latent intracortical connections. Science 1991, 251:944-947.
21. Hess G, Donoghue JP: Long-term potentiation of horizontal connections provides a mechanism to reorganize cortical motor maps. J Neurophysiol 1994, 71:2543-2547.
22. Garraghty PE, Muja N: NMDA receptors and plasticity in adult primate somatosensory cortex. J Comp Neurol 1996, 367:319-326.
23. Liepert J: TMS mapping studies in peripheral and central lesions. Electroencephalogr Clin Neurophysiol Suppl 1999, 51:151-156.
24. Karl A, Birbaumer N, Lutzenberger W, Cohen LG, Flor H: Reorganization of motor and somatosensory cortex in upper extremity amputees with phantom limb pain. J Neurosci 2001, 21:3609-3618.
25. Kornhuber J, Bormann J, Hubers M, Rusche K, Riederer P: Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. Eur J Pharmacol 1991, 206:297-300.
26. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G: Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci Biobehav Rev 1997, 21:455-468.
27. Parsons CG, Danysz W, Quack G: Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 1999, 38:735-767.
28. Schugens MM, Egerter R, Daum I, Schepelmann K, Klockgether T, Loschmann PA: The NMDA antagonist memantine impairs classical eyeblink conditioning in humans. Neurosci Lett 1997, 224:57-60.
29. Stefan K, Kunesch E, Benecke R, Cohen LG, Classen J: Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol 2002, 543:699-708.
30. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W: Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996, 40:367-378.
31. Chen R, Samii A, Canos M, Wassermann EM, Hallett M: Effects of phenytoin on cortical excitability in humans. Neurology 1997, 49:881-883.
32. Schwenkreis P, Witscher K, Janssen F, Addo A, Dertwinkel R, Zenz M, Malin JP, Tegenthoff M: Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability. Neurosci Lett 1999, 270:137-140.
33. Ridding MC, Rothwell JC: Stimulus/response curves as a method of measuring motor cortical excitability in man. Electroencephalogr Clin Neurophysiol 1997, 105:340-344.
34. Mano Y, Nakamuro T, Tamura R, Takayanagi T, Kawanishi K, Tamai S, Mayer RF: Central motor reorganization after anastomosis of the musculocutaneous and intercostal nerves following cervical root avulsion [see comments]. Ann Neurol 1995, 38:15-20.
35. Traversa R, Cicinelli P, Bassi A, Rossini PM, Bernardi G: Mapping of motor cortical reorganization after stroke. A brain stimulation study with focal magnetic pulses. Stroke 1997, 28:110-117.
36. Nudo RJ, Milliken GW, Jenkins WM, Merzenich MM: Use-dependent alterations of movement representations in primary motor cortex of adult squirrel monkeys. J Neurosci 1996, 16:785-807.
37. Hebb DO: The organization of behaviour. New York, Wiley and Sons; 1949.
38. Manallack DT, Lodge D, Beart PM: Subchronic administration of MK-801 in the rat decreases cortical binding of [3H]D-AP5, suggesting down-regulation of the cortical N-methyl-D-aspartate receptors. Neuroscience 1989, 30:87-94.
39. Beart PM, Lodge D: Chronic administration of MK-801 and the NMDA receptor: further evidence for reduced sensitivity of the primary acceptor site from studies with the cortical wedge preparation. J Pharm Pharmacol 1990, 42:354-355.
40. Nikolajsen L, Gottrup H, Kristensen AG, Jensen TS: Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. Anesth Analg 2000, 91:960-966.
41. Maier C, Dertwinkel R, Mansourian N, Hosbach I, Schwenkreis P, Senne I, Skipka G, Zenz M, Tegenthoff M: Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain - results of a randomized double-blinded, placebo-controlled trial. Pain 2003, 103:277-283.
42. Wiech K, Kiefer RT, Topfner S, Preissl H, Braun C, Unertl K, Flor H, Birbaumer N: A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain. Anesth Analg 2004, 98:408-13, table of contents.
43. Kornhuber J, Quack G: Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. Neurosci Lett 1995, 195:137-139.
44. Danysz W, Gossel M, Zajaczkowski W, Dill D, Quack G: Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? - case of amantadine and memantine. J Neural Transm Park Dis Dement Sect 1994, 7:155-166.
45. Spanagel R, Eilbacher B, Wilke R: Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur J Pharmacol 1994, 262:21-26.
46. Rothwell JC, Hallett M, Berardelli A, Eisen A, Rossini P, Paulus W: Magnetic stimulation: motor evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999, 52:97-103.